SCND — Scientific Industries Balance Sheet
0.000.00%
- $7.96m
- -$0.34m
- $10.71m
- 38
- 64
- 28
- 39
Annual balance sheet for Scientific Industries, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-Q | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 7.89 | 13.4 | 9.36 | 5.72 | 2.57 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.4 | 1.63 | 1.66 | 1.32 | 1.28 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 12.7 | 18.4 | 16.3 | 12.3 | 8.29 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.08 | 1.08 | 2.48 | 2.36 | 1.83 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 14.8 | 29 | 29 | 16.7 | 11.6 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.19 | 2.29 | 2.23 | 1.84 | 1.75 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3.08 | 2.78 | 3.47 | 2.85 | 2.44 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 11.7 | 26.2 | 25.6 | 13.9 | 9.12 |
| Total Liabilities & Shareholders' Equity | 14.8 | 29 | 29 | 16.7 | 11.6 |
| Total Common Shares Outstanding |